MICHELLE RALEY DRUG DELIVERY LEADER ARTICLES
-
Advancing Multi-Pathology Disease-Modifying Therapy For Neurodegenerative Diseases10/6/2026
We discuss Amyl’s approach to developing therapeutics designed to target multiple amyloid fibrils and the use of brain shuttle technology to enhance delivery across the blood-brain barrier.